Work

Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-148049

Authors: Clara Chen, Gerwin A. Huls, Heather Cameron, Beatrice Suero, Alberto Vasconcelos, Lona Gaugler, C.L. Beach

Institutions: Bristol-Myers Squibb (United States), University Medical Center Groningen, University of Groningen, EVERSANA (Canada)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211546201

Cites:

Cited by: 2

Related to: 10